This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
OncLive
onclive.bsky.social
did:plc:b6or56vkmhywvtt2wkcsnbsc
🧬 The combination of palbociclib plus anastrozole demonstrated encouraging efficacy with a manageable safety profile in patients with ER-positive recurrent endometrial cancer.
Read more ➡️ https://www.onclive.com/view/palbociclib-plus-anastrozole-is-safe-and-effective-in-er-recurrent-endometrial-cancer
#EndometrialCancer #GynecologicCancer #Oncology #ESMOGyn26 #gynsm
2026-06-19T13:20:23.971Z